Abstract
New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Current Proteomics
Title: New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis
Volume: 1 Issue: 1
Author(s): Corinne Stannard, Larry R. Brown and Jasminka Godovac-Zimmermann
Affiliation:
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Abstract: New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Export Options
About this article
Cite this article as:
Stannard Corinne, Brown R. Larry and Godovac-Zimmermann Jasminka, New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488243
DOI https://dx.doi.org/10.2174/1570164043488243 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thioguanine, Mercaptopurine: Their Analogs and Nucleosides as Antimetabolites
Current Pharmaceutical Design Anabolic Factors in Degenerative Joint Disease
Current Drug Targets Mesothelioma - Epidemiology and Management
Current Respiratory Medicine Reviews Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types
Current Drug Targets Antiviral Medication in Sexually Transmitted Diseases. Part II: HIV
Mini-Reviews in Medicinal Chemistry Inpatient Care of the HIV Infected Patient in the Highly Active Antiretroviral Therapy (HAART) Era
Current HIV Research Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo
Current Cancer Drug Targets Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
Current Drug Metabolism Evidence for Up-Regulation of Purinergic Receptor Genes Associating with TRPV1 Receptors and Neurotrophic Factors in the Inflamed Human Esophagus
Current Molecular Medicine Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Ghetto Poverty and Pollution in Egypt: A Deadly Threat for Western Countries Caused by New and Infectious Mutants. A Cultural, Social and Microbiological Synopsis
Inflammation & Allergy - Drug Targets (Discontinued) Effect of SDF-1 α on Endogenous Mobilized and Transplanted Stem Cells in Regeneration after Myocardial Infarction
Current Pharmaceutical Design Nanodiamonds as a New Horizon for Pharmaceutical and Biomedical Applications
Current Drug Delivery From Small to Powerful: The Fragments Universe and its “Chem-Appeal”
Current Medicinal Chemistry Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase IIα As Novel Anticancer Agents
Current Medicinal Chemistry The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry